Vega RGB

Language: Spanish
References: 14
Page: 136-138
PDF size: 36.15 Kb.

Text Extraction

No abstract

REFERENCES

1. Teng G, Papavasiliou F. Immunoglobulin somatic hypermutation. Annu Rev Genet 2007; 41: 107-20.

2. Abbas AK, Lichtman, Pillai S. Cellular and molecular immunology. Philadelphia. Saunders Elsevier. 6th edition. 2007.

3. Harris L, Larse S, McPherson A. Comparison of intact antibody structures and the implications for effector functions. Adv Immunol 1999; 72: 191-208.

4. Bartemes K, Kate B, Cooper B. Secretory IgA induces eosinophil survival and cytokine production without inducing effector functions. J Allergy Clin Immunol 2005; 116: 827-35.

5. Schaedel O, Reiter Y. Antibodies and their fragments as anti-cancer agents. Oncogene 2007; 26(25): 3714-33.

6. Saerens D, Ghassabek G, Neuyldermans S. Single-domain antibodies as building blocks for novel therapeutics. Curr Opin Pharmacol 2008; 8(5): 600-8.

7. Kraft S, Novak N. Fc receptors as determinants of allergic reactions. Trends Immunol 2006; 27: 88-94.

8. Teng G, Papavasiliou F. Immunoglobulin somatic hypermutation. Annu Rev Genet 2007; 41: 107-20.

9. Abbas AK, Lichtman, Pillai S. Cellular and molecular immunology. Philadelphia. Saunders Elsevier. 6th edition. 2007.

10. Harris L, Larse S, McPherson A. Comparison of intact antibody structures and the implications for effector functions. Adv Immunol 1999; 72: 191-208.

11. Bartemes K, Kate B, Cooper B. Secretory IgA induces eosinophil survival and cytokine production without inducing effector functions. J Allergy Clin Immunol 2005; 116: 827-35.

12. Schaedel O, Reiter Y. Antibodies and their fragments as anti-cancer agents. Oncogene 2007; 26(25): 3714-33.

13. Saerens D, Ghassabek G, Neuyldermans S. Single-domain antibodies as building blocks for novel therapeutics. Curr Opin Pharmacol 2008; 8(5): 600-8.

14. Kraft S, Novak N. Fc receptors as determinants of allergic reactions. Trends Immunol 2006; 27: 88-94.